Weaver C. Barksdale & Associates’s MetLife MET Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.56M	Buy	22,023 +1,230	+6%	+$92.1K	1.49%	44
2025 Q4	$1.64M	Sell	20,793 -2,672	-11%	-$211K	1.72%	32
2025 Q3	$1.93M	Sell	23,465 -1,501	-6%	-$118K	1.86%	23
2025 Q2	$2.01M	Sell	24,966 -245	-1%	-$18.9K	1.92%	18
2025 Q1	$2.02M	Sell	25,211 -599	-2%	-$49.8K	1.94%	18
2024 Q4	$2.11M	Sell	25,810 -641	-2%	-$53.3K	2.02%	16
2024 Q3	$2.18M	Sell	26,451 -999	-4%	-$74.6K	1.97%	17
2024 Q2	$1.93M	Sell	27,450 -438	-2%	-$31.3K	1.83%	23
2024 Q1	$2.07M	Sell	27,888 -223	-0.8%	-$15.5K	1.9%	20
2023 Q4	$1.86M	Sell	28,111 -7,191	-20%	-$450K	1.82%	20
2023 Q3	$2.22M	Buy	35,302 +5,542	+19%	+$345K	1.89%	20
2023 Q2	$1.68M	Sell	29,760 -1,821	-6%	-$101K	1.66%	38
2023 Q1	$1.83M	Sell	31,581 -1,518	-5%	-$102K	1.71%	31
2022 Q4	$2.4M	Buy	33,099 +837	+3%	+$60K	2.11%	2
2022 Q3	$1.96M	Sell	32,262 -1,152	-3%	-$73.6K	1.97%	7
2022 Q2	$2.1M	Buy	33,414 +1,981	+6%	+$131K	1.95%	8
2022 Q1	$2.21M	Buy	31,433 +418	+1%	+$28.3K	1.97%	9
2021 Q4	$1.94M	Buy	+31,015	New	+$1.95M	1.76%	29

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Weaver C. Barksdale & Associates's MET Position: Q1 2026 in Review

Weaver C. Barksdale & Associates increased its MetLife (MET) stake by 5.9% in Q1 2026, buying an estimated $92.1K and bringing the position to 22,023 shares worth $1.56M. The position accounts for 1.49% of the portfolio, ranked #44.

Weaver C. Barksdale & Associates first reported a position in MET in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.4M in Q4 2022. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

Weaver C. Barksdale & Associates held 22,023 shares of MetLife worth $1.56M as of Q1 2026.
Weaver C. Barksdale & Associates bought 1,230 MetLife shares in Q1 2026, an estimated $92.1K.
MetLife made up 1.49% of Weaver C. Barksdale & Associates's portfolio in Q1 2026, its #44 holding.
Weaver C. Barksdale & Associates first reported a position in MetLife in Q4 2021 and has held it in 18 quarters since.
Weaver C. Barksdale & Associates's MetLife position peaked at $2.4M in Q4 2022.
1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Weaver C. Barksdale & Associates's 13F filing for Q1 2026, filed 14 May 2026.